NCT03717168View on ClinicalTrials.gov

Effects of Growth Hormone on Difficult Ventilator Weaning Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

August 30, 2018

Study Completion Date

August 30, 2018

Conditions
Mechanical Ventilation Complication
Interventions
DRUG

Recombinant human growth hormone

All the patients received subcutaneous rHGH (0.3 IU/kg/ twice daily) for 10 days in addition to intensive care standard management.

OTHER

Control

All patients will not receive growth hormone.

Trial Locations (1)

11796

Department of Anesthesia and Pain medicine.National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT03717168 - Effects of Growth Hormone on Difficult Ventilator Weaning Patients | Biotech Hunter | Biotech Hunter